DE3782619D1 - 1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente. - Google Patents

1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente.

Info

Publication number
DE3782619D1
DE3782619D1 DE8787115591T DE3782619T DE3782619D1 DE 3782619 D1 DE3782619 D1 DE 3782619D1 DE 8787115591 T DE8787115591 T DE 8787115591T DE 3782619 T DE3782619 T DE 3782619T DE 3782619 D1 DE3782619 D1 DE 3782619D1
Authority
DE
Germany
Prior art keywords
hydroxyalkylxanthine
production
same
products containing
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787115591T
Other languages
English (en)
Other versions
DE3782619T2 (de
Inventor
Rene Fumeaux
Georges Philipposian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of DE3782619D1 publication Critical patent/DE3782619D1/de
Publication of DE3782619T2 publication Critical patent/DE3782619T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
DE8787115591T 1986-10-27 1987-10-23 1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente. Expired - Fee Related DE3782619T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4253/86A CH670090A5 (de) 1986-10-27 1986-10-27

Publications (2)

Publication Number Publication Date
DE3782619D1 true DE3782619D1 (de) 1992-12-17
DE3782619T2 DE3782619T2 (de) 1993-04-22

Family

ID=4272668

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787115591T Expired - Fee Related DE3782619T2 (de) 1986-10-27 1987-10-23 1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente.

Country Status (13)

Country Link
EP (1) EP0269841B1 (de)
JP (1) JP2527769B2 (de)
KR (1) KR930010559B1 (de)
AT (1) ATE82289T1 (de)
AU (1) AU604767B2 (de)
CA (1) CA1296001C (de)
CH (1) CH670090A5 (de)
DE (1) DE3782619T2 (de)
DK (1) DK169336B1 (de)
ES (1) ES2043631T3 (de)
GR (1) GR3006223T3 (de)
IL (1) IL84266A (de)
ZA (1) ZA877851B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
DE4316576A1 (de) * 1993-05-18 1994-11-24 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 1,3-Dipropyl-8-(3-Oxocyclopentyl)-xanthin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Also Published As

Publication number Publication date
EP0269841A1 (de) 1988-06-08
DE3782619T2 (de) 1993-04-22
KR930010559B1 (ko) 1993-10-28
DK169336B1 (da) 1994-10-10
IL84266A (en) 1992-02-16
GR3006223T3 (de) 1993-06-21
ES2043631T3 (es) 1994-01-01
AU604767B2 (en) 1991-01-03
CA1296001C (en) 1992-02-18
DK551487D0 (da) 1987-10-21
JP2527769B2 (ja) 1996-08-28
ZA877851B (en) 1988-04-22
DK551487A (da) 1988-04-28
ATE82289T1 (de) 1992-11-15
AU7998087A (en) 1988-04-28
JPS63122683A (ja) 1988-05-26
KR880005131A (ko) 1988-06-28
CH670090A5 (de) 1989-05-12
IL84266A0 (en) 1988-03-31
EP0269841B1 (de) 1992-11-11

Similar Documents

Publication Publication Date Title
NZ221158A (en) (2-aminoethoxy)phenoxyacetamide derivatives and pharmaceutical compositions thereof
PT76450A (de) Spiro/4.(3+n)-2-aza-3-carbonsaeure-derivate verfahren zu ihrer herstellung diese enthaltende mittel und ihre verwendung
DE69110625D1 (de) Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen.
ATE9793T1 (de) 5-oxo- und 5-thioxoproline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE69025104D1 (de) Thiazolderivate, Verfahren zur Ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE69215965T2 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
DE3868013D1 (de) Thiazolderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ATE41659T1 (de) Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE3782619D1 (de) 1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente.
PL286188A1 (en) Method of obtaining renine retarding aminooligohydroxy derivatives
DE3885978T2 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung.
ZA948515B (en) Cyclised analogues of fatty acid metabolites,a process for their preparation and pharmaceutical compositions containing them
ATE89270T1 (de) Quaternaere ammoniumsalze, verfahren zu deren herstellung und verwendung derselben.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee